Stability of Medications Administered via Enteral Feeding Tubes: A Systematic Review
Open Access
- 24 December 2025
- journal article
- review article
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (1) , e70427
Abstract
Feeding tubes are essential for patients unable to maintain adequate oral intake, serving multiple purposes including nutrition delivery and medication administration. The impact of administering medications through feeding tubes on their stability requires systematic investigation. This review aims to systematically evaluate factors affecting medication stability when administered via enteral feeding tubes versus oral administration in healthy populations, focusing on solid dosage forms converted to liquid formulations. A comprehensive search was conducted across PubMed/MEDLINE, Embase, and CINAHL databases from July to October 2024, using a combination of MeSH and non‐MeSH terms. Studies that assessed medication stability in enteral feeding tubes were included, while those that did not report on this outcome were excluded. The risk of bias was evaluated using ROBINS‐I, RoB‐ II, Cochrane tools, and the QUIN tool. From 2368 articles, 115 were retained for further assessment, and finally 24 met the inclusion criteria and were included, comprising 16 in vivo, 4 in vitro, and 4 combined studies. Approximately 20.8% of the studies found reduced stability/bioavailability for certain medications, such as warfarin and tolvaptan, while 8.3% of the studies found enhanced absorption, as observed with clopidogrel. Most medications maintained their stability. This systematic review suggests that enteral feeding tube administration can variably affect medication stability, influenced by factors such as tube material and preparation methods. Although most medications remain stable, concerns regarding instability and quality persist. The findings of this review provide a foundation for developing evidence‐based guidelines to optimize clinical practice and improve patient outcomes.Keywords
This publication has 39 references indexed in Scilit:
- Effects of Enteral Feeding on the Oral Bioavailability of Moxifloxacin in Healthy VolunteersClinical Pharmacokinetics, 2005
- Relative bioavailability and safety profile of gefitinib administered as a tablet or as a dispersion preparation via drink or nasogastric tube: results of a randomized, open-label, three-period crossover study in healthy volunteersClinical Therapeutics, 2004
- A novel option in proton pump inhibitor dosing: lansoprazole orally disintegrating tablet dispersed in water and administered via nasogastric tubeAlimentary Pharmacology & Therapeutics, 2004
- Bioequivalence of ximelagatran, an oral direct thrombin inhibitor, as whole or crushed tablets or dissolved formulationCurrent Medical Research and Opinion, 2004
- Esomeprazole administered through a nasogastric tube provides bioavailability similar to oral dosingAlimentary Pharmacology & Therapeutics, 2003
- Oral bioavailability of pantoprazole suspended in sodium bicarbonate solutionAmerican Journal of Health-System Pharmacy, 2003
- Comparative pharmacokinetics and pharmacodynamics of lansoprazole oral capsules and suspension in healthy subjectsAmerican Journal of Health-System Pharmacy, 2001
- Bioavailability of a crushed pantoprazole tablet after buffering with sodium hydrogencarbonate or magaldrate relative to the intact enteric coated pantoprazole tabletMethods and Findings in Experimental and Clinical Pharmacology, 2001
- The bioavailability of nasogastric versus tablet-form oral trovafloxacin in healthy subjectsThe American Journal of Surgery, 1998
- Bioavailability and efficacy of omeprazole given orally and by nasogastric tubeDigestive Diseases and Sciences, 1996